Skip to main content

US Pharmacy Market [2022-2028] | to Reach USD 861.67 Billion by 2028, at a CAGR of 6.3%

Written by Customer Service on . Posted in Mergers And Acquisitions.

Key Prominent Players Covered in the US Pharmacy Market are CVS Health Corporation (Rhode Island, U.S.), Walgreens Boots Alliance, Inc. (Illinois, U.S.), Cigna (Express Scripts) (Connecticut, U.S.), UnitedHealth Group (Optum) (Minnesota, U.S.), Walmart Inc. (Arkansas, U.S.), The Kroger Company (Ohio, U.S.), Rite Aid Corporation (Pennsylvania, U.S.), Albertsons Companies, Inc. (Idaho, U.S.)

Pune, India, Feb. 01, 2022 (GLOBE NEWSWIRE) — The US Pharmacy Market size was USD 534.21 billion in 2020. The market is projected to grow from USD 560.00 billion in 2021 to USD 861.67 billion by 2028 at a CAGR of 6.3% in the 2021-2028 period.

This information is published by Fortune Business Insights™, in its report, titled, “US Pharmacy Market, 2021-2028.”

According to our expert researchers, surging occurrence of aliments in the U.S., growing geriatric population, and rising healthcare spending are few of the prime aspects fueling the growth of the pharmaceuticals market in the country.

Industry Development

January 2021 – Optum (UnitedHealth Group) collaborated with Change Healthcare, to offer software and data analytics, technology-empowered facilities and research, advisory and revenue cycle management offerings to assist in making health care work refined for all.


Request a Sample Copy of the Research Report

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/u-s-pharmacy-market-106306


Growing Occurrence of Prolonged Disease and High Geriatric Population to Spur Demand

The amount of chronic disease-inflicted patients is promptly surging globally. There has been an incredible growth in the occurrences of chronic immune deficiencies, diabetes, and congestive heart failure among others. As per a record published by World Health Organization (WHO), chronic ailments impact nearly 133 million Americans, portraying 40% of the total population of the nation. Moreover, the growth in the geriatric population in the nation is also aiding the US Pharmacy Market growth.

Nevertheless, the difficulties linked with the usage of these are a prime aspects that are probable to obstruct the growth of this market in the upcoming years.


To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit:

https://www.fortunebusinessinsights.com/u-s-pharmacy-market-106306


Type, Therapy Class, and Setting are studied for the Market

On the basis of type, the market is segregated into branded and generics. Branded drugs held a leading market share in 2020. The rising number of regulatory approvals for drugs coupled with a strong pipeline of dominating players is majorly responsible for its highest market share during the forecast period.

In terms of therapy class, the market is classified into oncology, anti-diabetics, autoimmune diseases, respiratory, pain, nervous system disorders, dermatology, antihypertensive, mental health, HIV antivirals, multiple sclerosis, anticoagulants, other cardiovascular, ADHD, GI products, viral hepatitis, sex hormones, antibacterial, hormonal contraception, ophthalmology, and others.

By setting, the market is divided into retail pharmacies, mail order/online pharmacies, and others.


Quick Buy US Pharmacy Market

https://www.fortunebusinessinsights.com/checkout-page/106306


Surging Consciousness Regarding Health amid COVID-19 Pandemic to Aid Market Growth

The COVID-19 pandemic has had an adverse sway on the pharmacy market. Vital players registered a considerable growth in their income levels from the pharmacy business due to the notable rise in the amount of patients gaining prescribed medicines at home during the COVID-19 lockdown. Furthermore, with the COVID-19 outbreak, the home care facilities attained more popularity, thereby sanctioning patients the safety of remaining in their houses and declining the threat of exposure to the virus. Henceforth, several local drugs perceived a rise in demand for delivery services and that resulted in an augmentation in prescription revenue.


Ask for Customization

https://www.fortunebusinessinsights.com/enquiry/customization/u-s-pharmacy-market-106306


Competitive Landscape

Collaborations among Companies to Safeguard Their Brand Values in Global Market

Fundamental players in the market are incessantly rooting for efficient tactics to endorse their products and establish their positions in the market. One such tactic is to launch novel products by teaming up with other companies to expand their reach to end-users.


List of Key Players Covered in this Market Report

  • CVS Health Corporation (Rhode Island, U.S.)
  • Walgreens Boots Alliance, Inc. (Illinois, U.S.)
  • Cigna (Express Scripts) (Connecticut, U.S.)
  • UnitedHealth Group (Optum) (Minnesota, U.S.)
  • Walmart Inc. (Arkansas, U.S.)
  • The Kroger Company (Ohio, U.S.)
  • Rite Aid Corporation (Pennsylvania, U.S.)
  • Albertsons Companies, Inc. (Idaho, U.S.)


Have Any Query? Ask Our Experts:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/u-s-pharmacy-market-106306


Table Of Content

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Chronic and Infectious Diseases in U.S., 2020
    • Key Industry Developments – Mergers, Acquisitions and Partnerships, 2020
    • Introduction of New Products / Approvals (By Major Players)
    • Impact of COVID-19 on US Pharmacy Market
  • US Pharmacy Market Analysis, Insights and Forecast, 2017-2028
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Type
      • Branded
      • Generics
    • Market Analysis, Insights and Forecast – By Therapy Class
      • Oncology
      • Anti-diabetics
      • Autoimmune diseases
      • Respiratory
      • Pain
      • Nervous System Disorders
      • Dermatology
      • Antihypertensive
      • Mental Health
      • HIV Antivirals
      • Multiple Sclerosis
      • Anticoagulants
      • Other Cardiovascular
      • ADHD
      • GI Products
      • Viral Hepatitis
      • Sex Hormones
      • Antibacterial
      • Hormonal Contraception
      • Ophthalmology
      • Others
    • Market Analysis, Insights and Forecast – By Setting
      • Retail Pharmacies
      • Mail Order/Online Pharmacies
      • Others (Non-retail Settings)


ToC Continue…!


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Contact Us:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email:sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.